Accelerated induction regimens of TNF-alpha inhibitors in patients with inflammatory bowel disease: a scoping review protocol.
Johnston, Amy; Natarajan, Sabrina; Hayes, Meghan; MacDonald, Erika; Shorr, Risa.
; 8(1): e019909, 2018 01 30.
Artigo em Inglês | MEDLINE | ID: mdl-29382683
Association between Genetic Polymorphisms and Response to Anti-TNFs in Patients with Inflammatory Bowel Disease.
A Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel disease.
The impact of biological interventions for ulcerative colitis on health-related quality of life.
The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
Outcome of inflammatory bowel disease patients treated with TNF-α inhibitors: two-year follow-up.
Use of a third anti-TNF after failure of two previous anti-TNFs in patients with inflammatory bowel disease: is it worth it?
Use of Biologics in Pouchitis: A Systematic Review.
Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNFα-blocking agents.
Enfermedad inflamatoria intestinal como efecto paradójico del tratamiento con anti-TNF-alfa
Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab.